Ashleigh Palmer Net Worth & Insider Trades
Ashleigh Palmer - Director and CEO, Provention Bio, Inc
What is Ashleigh Palmer's Net Worth?
The current estimated net worth of Provention Bio, Inc's Director and CEO, Ashleigh Palmer, is estimated to be about $62.52M . Ashleigh Palmer owns about 2,570,050 units of Provention Bio, Inc common stock. In the last 5 years at Provention Bio, Inc, Ashleigh Palmer has sold an estimated value of $1.01M worth.
What is Ashleigh Palmer's Past Insider Trading?
Ashleigh Palmer's largest purchase order was 75,835 units , worth over $189.59K on February 14, 2023. Ashleigh Palmer's largest sale order was 75,835 units , worth over $765K on February 14, 2023. In total, Ashleigh Palmer has made about 19 transactions over 5 years of their time at Provention Bio, Inc. Ashleigh Palmer usually trades in December, with the busiest year in 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ashleigh Palmer
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Ashleigh Palmer's' Mailing Address?
- Mailing address is Provention Bio, Inc. 110 Old Driftway Lane Lebanon NJ 08833 NJ
What are Provention Bio, Inc's Past Insider Trades?
Provention Bio, Inc's most recent insider trade came on April 18, 2023 by Sessa Capital Master Lp, Sessa Capital GP Llc, Sessa Capital Im Lp, Sessa Capital Im GP Llc and John Petry who sold 2,190,549 units worth $53.27M . In the last 5 years, insiders at Provention Bio, Inc have sold an estimated value of $85.68M and bought an estimated value of $59.76M worth of shares. Insider trading is most common in December, with the busiest year in 2023. The most active traders at the company are Francisco Leon, Chief Scientific Officer, Anthony Digiandomenico, Director, and Ashleigh Palmer, Director and CEO .
Provention Bio, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |